Submission date
29/09/2006
Registration date
29/09/2006
Last edited
12/05/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Retrospectively registered
? Protocol not yet added
? SAP not yet added
? Results not yet added and study completed for more than 2 years
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr Rob Niven

ORCID ID

Contact details

North West Lung Centre
South Manchester University Hospitals NHS Trust
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom
+44 (0)161 291 2846
Robert.Niven@smuht.nwest.nhs.uk

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

N0226167744

Study information

Scientific title

Randomised controlled trial of treating dysfunctional breathing to reduce breathlessness in severe asthma

Acronym

Study hypothesis

To improve thoraco-abdominal co-ordination and hence reduce breathlessness.

Ethics approval(s)

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Not specified

Study type

Treatment

Patient information sheet

Condition

Respiratory: Asthma

Intervention

1. Patients will undergo breathing retraining with senior physiotherapist
2. Control

Intervention type

Other

Primary outcome measure

Change in University of California San Diego Shortness-of-Breath Questionnaire (SOBQ) score after treatment for dysfunctional breathing

Secondary outcome measures

Not provided at time of registration

Overall study start date

06/04/2004

Overall study end date

15/12/2005

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

31 patients suffering from severe asthma:
1. Patients with diagnosis of asthma requiring regular maintenance medication (that includes high dose inhaled corticosteroid and long-acting Β2 agonist)
2. High medical resource usage
3. Non-smoker for at least one year
4. Historical evidence of reversibility

Participant type(s)

Patient

Age group

Adult

Sex

Both

Target number of participants

31

Participant exclusion criteria

1. Previous treatment for hyperventilation, dysfunctional breathing, or other functional disorder of respiratory mechanics
2. Participation in another trial involving respiratory intervention
3. Current or recent lower respiratory tract infection
4. Presence of other respiratory diseases
5. DLCO <70% predicted, significant co-morbid illness
6. Pregnancy or nursing mother
7. Psychiatric disorder
8. Hospitalisation for asthma within the prior 6 weeks

Recruitment start date

06/04/2004

Recruitment end date

15/12/2005

Locations

Countries of recruitment

England, United Kingdom

Study participating centre

North West Lung Centre
Manchester
M23 9LT
United Kingdom

Sponsor information

Organisation

Record Provided by the NHSTCT Register - 2006 Update - Department of Health

Sponsor details

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Funder name

South Manchester University Hospitals NHS Trust (UK) NHS R&D Support Funding

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?

Additional files

Editorial Notes